Regenxbio (RGNX) EPS (Basic) (2014 - 2025)

Regenxbio's (RGNX) quarterly EPS (Basic) came in at $1.74 in Q4 2025, up 229.43% year-on-year from $0.53 in Q4 2024, and up 237.48% quarter-over-quarter from -$1.27 in Q3 2025.

Regenxbio (RGNX) EPS (Basic) (2014 - 2025) Analysis & Trends

Regenxbio's EPS (Basic) history runs 12 years deep, the most recent figure standing at $1.74 for Q4 2025.

  • On a quarterly basis, EPS (Basic) rose 229.43% year-over-year to $1.74 in Q4 2025; TTM through Dec 2025 was -$0.83, a 83.79% increase from a year earlier, with the FY2025 full-year figure at -$10.38, down 122.95% from the prior year.
  • EPS (Basic) climbed to $1.74 in Q4 2025 per RGNX's latest filing, from -$1.27 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $6.93 in Q4 2021 and bottomed at -$1786.6 in Q1 2022.
  • The 5-year median for EPS (Basic) is -$1.36 (2021), against an average of -$485.45.
  • Across the five-year window, EPS (Basic) jumped 658.58% in 2021 and sank 148911.94% in 2022, its largest moves.
  • Year by year, EPS (Basic) stood at $6.93 in 2021, then retreated by 6.61% to $6.47 in 2022, then slumped by 122.25% to -$1.44 in 2023, then increased by 6.54% to -$1.35 in 2024, then jumped by 229.43% to $1.74 in 2025.
  • Per Business Quant, the three latest RGNX EPS (Basic) figures stand at $1.74 (Q4 2025), -$1.27 (Q3 2025), and -$1.38 (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 0.00
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 0.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 0.16
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 4.06
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 6.99
7 Belite Bio 61.40 Bn 61.40 Bn - 0.00
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 5.90
9 Revolution Medicines 37.37 Bn 37.37 Bn - -2.29
10 Regenxbio 501.81 Mn 271.74 Mn 21.22 Mn 1.74

Historic Data

Download Data
DateValue
Dec 31, 2025 1.74
Sep 30, 2025 -1.27
Jun 30, 2025 -1.38
Mar 31, 2025 0.07
Dec 31, 2024 -1.35
Sep 30, 2024 -1.18
Jun 30, 2024 -1.07
Mar 31, 2024 -1.62
Dec 31, 2023 -1.44
Sep 30, 2023 -1,407.85
Jun 30, 2023 -1,655.40
Mar 31, 2023 -1,534.51
Dec 31, 2022 6.47
Sep 30, 2022 -1,745.25
Jun 30, 2022 -1,581.48
Mar 31, 2022 -1,786.58
Dec 31, 2021 6.93
Sep 30, 2021 -1.37
Jun 30, 2021 -1.36
Mar 31, 2021 -1.20